Lixin Zhou
Research Center For Economy Of Upper Reaches Of The Yangtse River
Chongqing, 400067, China
Chongqing, 400067, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intermediate-dose cytarabine alone versus combination in consolidation therapy for non-transplant acute myeloid leukemia: a retrospective study.
Journal: Annals of medicine
Published: June 09, 2025
The impact of de-familization on green innovation: Evidence from SRDI family firms in China.
Journal: PloS one
Published: February 20, 2024
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
Journal: Molecular carcinogenesis
Published: September 20, 2022
The Impact of Intergenerational Succession Intention on Family Firm's Innovation Strategy: Evidence from China.
Journal: Journal of the knowledge economy
Published: December 11, 2021
TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia.
Journal: Translational cancer research
Published: September 24, 2021
Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells.
Journal: Translational cancer research
Published: January 08, 2021
High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials.
Journal: PloS one
Published: February 06, 2015
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Journal: Annals of clinical microbiology and antimicrobials
Published: July 17, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026